Common Contracts
3 similar Warrant Agreement contracts by CytomX Therapeutics, Inc.
WARRANT TO PURCHASE PREFERRED STOCKWarrant Agreement • August 28th, 2015 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
THIS WARRANT CERTIFIES THAT, for the agreed upon value of $1.00 and for other good and valuable consideration, including the execution and delivery of that certain Master Loan and Security Agreement No. CYTOY, dated as of December 20, 2013, (the “Loan”), this Warrant is issued to ATEL VENTURES, INC., in its capacity as Trustee for its assignee affiliated funds identified in that certain Amendment and Restatement of Inter-Company Trust Agreement for Warrants dated as of January 1, 2007, as amended by Amendment No. 1 dated as of March 15, 2010 and Amendment No. 2 dated as of July 17, 2013, and as may be further amended and restated from time to time, and deemed effective as of July 20, 2004 (“Holder”), by CYTOMX THERAPEUTICS, INC., a Delaware corporation (the “Company”).
WARRANT TO PURCHASE PREFERRED STOCK Issuer: CYTOMX THERAPEUTICS, INC., a Delaware corporation Number of Shares: 291,048 Shares (or as otherwise determined in Section 1 below) Class of Stock: Series B-1 Preferred Stock, $0.00001 par value Exercise...Warrant Agreement • August 28th, 2015 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
THIS WARRANT CERTIFIES THAT, for the agreed upon value of $1.00 and for other good and valuable consideration, including the execution and delivery of that certain Master Loan and Security Agreement No. CYTOX, dated as of May 31, 2012, as amended by Amendment No. 1 dated as of January 31, 2013, (the “Loan”), this Warrant is issued to ATEL VENTURES, INC., in its capacity as Trustee for its assignee affiliated funds identified in that certain Amendment and Restatement of Inter-Company Trust Agreement for Warrants dated as of January 1, 2007, as amended by Amendment No. 1 dated as of March 15, 2010, and as may be further amended and restated from time to time, and deemed effective as of July 20, 2004 (“Holder”), by CYTOMX THERAPEUTICS, INC., a Delaware corporation (the “Company”).
WARRANT TO PURCHASE PREFERRED STOCK Issuer: CYTOMX THERAPEUTICS, INC., a Delaware corporation Number of Shares: 291,048 Shares (or as otherwise determined in Section 1 below) Class of Stock: Series B-1 Preferred Stock, $0.00001 par value Exercise...Warrant Agreement • July 24th, 2015 • CytomX Therapeutics, Inc. • Pharmaceutical preparations • California
THIS WARRANT CERTIFIES THAT, for the agreed upon value of $1.00 and for other good and valuable consideration, including the execution and delivery of that certain Master Loan and Security Agreement No. CYTOX, dated as of May 31, 2012, as amended by Amendment No. 1 dated as of January 31, 2013, (the “Loan”), this Warrant is issued to ATEL VENTURES, INC., in its capacity as Trustee for its assignee affiliated funds identified in that certain Amendment and Restatement of Inter-Company Trust Agreement for Warrants dated as of January 1, 2007, as amended by Amendment No. 1 dated as of March 15, 2010, and as may be further amended and restated from time to time, and deemed effective as of July 20, 2004 (“Holder”), by CYTOMX THERAPEUTICS, INC., a Delaware corporation (the “Company”).
